ClinicalTrials.gov
public full text
Public Domain
miRNA and Relevant Biomarkers of BC Patients Undergoing Neoadjuvant Treatment
MicroRNA (miRNA) is a type of endogenous non-coding RNA. They are responsible for post-transcriptional regulation and participate in many vital biological processes. Expression profiling has shown that miRNAs can distinguish between normal breast and tumor tissues. In recent years, circulating miRNAs have become promising biomarkers based on their stability and their non-invasive testing and feasibility in clinical practices.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis#814026
- Integrating Serum Lipid Biomarkers Into Machine Learning for the Differential Diagnosis of Breast Nodules.#479257
- Advancements in Early Detection of Breast Cancer: Innovations and Future Directions#97827
- A comparative evaluation of quantum machine learning architectures for breast cancer classification using clinical and genomic data.#452950
- Circulating microRNAs for Discriminating Obese Preschoolers at Risk of Diabetes#1101989
Record · ID 870901
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive